Pfizer to study COVID-19 pill for kids
Published: Feb. 9, 2022 at 8:10 AM EST
(CNN) - Pfizer is working to get its COVID-19 fighting pill used in more people.
Paxlovid is currently authorized to treat COVID-19 in high-risk individuals 12 and older.
Pfizer is planning to study the drug in children age 6 to 18.
The pharmaceutical giant is also awaiting full approval from the Food and Drug Administration on the pill for the groups it is currently authorized to treat.
The company said it expects that decision in the second half of the year.
Pfizer’s chief scientific officer said the company is also working on a next generation pill to help treat COVID-19.
Copyright 2022 CNN Newsource. All rights reserved.
